视网膜母细胞瘤的治疗研究进展  

Research progress in the treatment of retinoblastoma

作　　者：邹宏密 简嘉[1] 周希瑗[1] Hong-Mi Zou;Jia Jian;Xi-Yuan Zhou(Department of Ophthalmology,the Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)

机构地区：[1]重庆医科大学附属第二医院眼科,中国重庆市400010

出　　处：《国际眼科杂志》2018年第8期1407-1410,共4页International Eye Science

基　　金：国家自然科学基金(No.81501487;81170858)~~

摘　　要：视网膜母细胞瘤(retinoblastoma,RB)是婴幼儿最常见的眼内恶性肿瘤,其发病与基因突变相关。为提高患儿生存率,降低眼球摘除率,治疗方法不断更新发展。目前主要治疗方法有化学治疗、放射治疗、手术治疗、物理治疗、光化学治疗、基因治疗等。本文就视网膜母细胞瘤的治疗进展进行综述。Retinoblastoma（ RB） is the most common intraocular malignant tumor in infants,the pathogenesis of which,is related to gene mutations. In order to improve the survival rate and eye-protection rate of RB patients,the therapeutic approaches have been constantly updated and developed, mainly including chemotherapy, radiation therapy, surgical treatment, physiotherapy,photochemotherapy, gene therapy at present. In this article,we mainly reviewed the progress of RB treatment.

关 键 词：视网膜母细胞瘤 治疗 

分 类 号：R739.7[医药卫生—肿瘤]